22157.jpg
TIL-based Therapies Market by Target Indications, Key Players and Key Geographies - Global Industry Trends and Forecasts, 2021-2030
July 23, 2021 04:13 ET | Research and Markets
Dublin, July 23, 2021 (GLOBE NEWSWIRE) -- The "TIL-based Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030" report has been...
22157.jpg
TCR-based Therapies Market Research Report 2021
July 16, 2021 04:58 ET | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "TCR-based Therapies Market by Target Indications, Target Antigens, Key Players and Key Geographies, Industry Trends and Global Forecasts, 2021-2030"...
22157.jpg
Global T-Cell Therapies Market Report 2021: Type of Therapy, Target Indications, Target Antigens, Key Players and Key Regions 2020-2030
February 19, 2021 04:33 ET | Research and Markets
Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "Global T-Cell Therapies Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key Players and Key Regions: Industry Trends and...
22157.jpg
T-Cell Immunotherapy Market Report 2021 - Global Forecast to 2025: Opportunities of Commercialisation and Funding by Pharmaceutical Companies
February 15, 2021 05:28 ET | Research and Markets
Dublin, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Research Report by Mechanism Of Action, by Type of Therapy, by Indication - Global Forecast to 2025 - Cumulative Impact of...
22157.jpg
Global CAR-T Pipeline Insight Report 2020: Overview, Landscape, Therapeutic Assessment, Current Treatment Scenario and Emerging Therapies
December 30, 2020 04:38 ET | Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "CAR-T - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. The "CAR-T - Pipeline Insight, 2020," report...
22157.jpg
Global T-Cell Immunotherapy Markets 2020-2025 by Mechanism Of Action, Type of Therapy, Product Class
October 20, 2020 05:18 ET | Research and Markets
Dublin, Oct. 20, 2020 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Research Report by Mechanism Of Action, by Product Class - Global Forecast to 2025 - Cumulative Impact of COVID-19" report...
IN8bioLogo.jpg
IN8bio Appoints Alan S. Roemer as Chairman
October 07, 2020 07:00 ET | IN8bio, Inc
NEW YORK, Oct. 07, 2020 (GLOBE NEWSWIRE) -- IN8bio, Inc., a clinical-stage biotechnology company focused on developing innovative allogeneic, autologous and genetically modified gamma-delta T cell...
jpg.jpg
First Patient Treated in Phase 1 Clinical Trial Of Incysus Therapeutics Gamma Delta (γδ) T Cell Immunotherapy for Patients With Newly Diagnosed Glioblastoma
June 02, 2020 07:00 ET | Incysus Therapeutics, Inc.
NEW YORK, June 02, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
jpg.jpg
Incysus Therapeutics Announces Poster Presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
May 28, 2020 07:00 ET | Incysus Therapeutics, Inc.
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
jpg.jpg
Incysus Therapeutics Treats First Patient in Phase 1 Study of Gamma Delta (γδ) T Cell Immunotherapy in Leukemia and Lymphoma Patients Undergoing Allogeneic Stem Cell Transplantation
May 12, 2020 07:00 ET | Incysus Therapeutics, Inc.
NEW YORK, May 12, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...